22 Jan 2024 – EyRIS is thrilled to announce that we have officially appointed One Health, a subsidiary of PureHealth, as our exclusive distributor within the United Arab Emirates (UAE). Recognized as the largest integrated healthcare provider in the UAE, PureHealth’s collaboration with EyRIS signifies the initiation of a transformative alliance poised to redefine healthcare standards across both public and…
Jan 2024 – A wonderful piece of news to kick-start the new year. A couple of years back, the EU Parliament legislated the transitional provisions from Medical Devices Directive (MDD) to Medical Devices Regulation (MDR). The new standard took into consideration the need for more stringent technical documentation, implementation of unique device identification (UDI) for better traceability and recall and…
Dec 2023 – EyRIS, the leading player in AI-driven healthcare solutions, is delighted to announce a strategic partnership with Advance Innovation, a collaboration that marks a momentous step forward in the enhancement and transformation of healthcare in Myanmar. The EyRIS team recently undertook a visit to Yangon, where they had the honor of engaging with distinguished medical professionals and key…
12 Dec 2023 – Nova MSC Berhad (“Nova MSC” or “the Company”), the parent company of EyRIS Pte Ltd (“EyRIS”), proudly announces that its state-of-the-art Artificial Intelligence (“AI”) tool, SELENA+, has been selected for the Sultanate of Oman’s National Diabetic Retinopathy (DR) Screening Program. This significant step underscores the global recognition and trust in EyRIS’s AI-driven solutions for enhancing healthcare…
29 Nov 2023 – The development of SELENA+ is now used as a business teaching case about how a locally-developed eye screening artificial intelligence (AI) system from inception to commercialisation by the start-up EyRIS. The complete journey is documented by a Singapore Management University (SMU) team led by Professor Emeritus of Information Systems Steven Miller, the case is being distributed…
5 Nov 2023 – Last week, Nova MSC received the physical copy of our ISO 9001:2015 re-certificate for the “Provision in design, development, implementation and maintenance of e-business solutions”. In the projects audited by Bureau Veritas, our team has demonstrated disciplined adherence to processes stipulated in our quality management system with ZERO non-compliances in our processes and one minor non-conformity…
15 Oct 2023 – EyRIS is thrilled to unveil a groundbreaking partnership with Mekdam Technology, one of Qatar’s premier technology conglomerates. This partnership introduces cutting-edge AI screening tools to accelerate early detection of medical conditions. The first AI to be introduced is SELENA+ which uncover eye diseases namely diabetic retinopathy, glaucoma and age-related macular degeneration. Additional AI algorithms will follow…
16 Oct 2023 – EyRIS is thrilled to announce a couple of partnerships in Yangon and Singapore to bring cutting-edge AI technology to Myanmar. In the near future, the cities of Yangon and Mandalay will witness the deployment of EyRIS’ state-of-the-art fully autonomous fundus camera, seamlessly integrated with our AI capabilities. This dynamic partnership is set to transform the landscape…
5 Sep 2023 – Nova has signed a landmark agreement with Theta Edge Berhad to establish a joint venture company to jointly market and implement state-of-the-art e-government solutions as well as a full range of IT services including system integration, consultancy and infrastructure system services in Malaysia. Nova MSC’s Executive Director, Mr Nazerollnizam Bin Kasim, said: “We are immensely proud…
21 Aug 2023 – We are thrilled to share that EyRIS has achieved a significant milestone by receiving TGA (Therapeutic Goods Administration) approval for the use of SELENA+ in Australia. This achievement underscores our commitment to detect retinal diseases and ultimately eliminate preventable blindness through early treatment on a global scale. A pivotal aspect of this achievement is our strategic…
26 Jun 2023 – Nova MSC Berhad (“NovaMSC” or “the Group”), a leading provider of software development and engineering solutions, is pleased to announce the appointment of Dato’ Adriana Law (below left) and Nazerollnizam Kasim (below right) as members of its Board of Directors. NovaMSC’s Executive Chairman, Mr Loh Guan Huat Sunny, warmly welcomed the new directors and said, “We…
7 June 2023 – EyRIS is thrilled to be selected to participate in a ground-breaking tripartite partnership with The International Centre for Eye Health at the London School of Hygiene and Tropical Medicine, University of London and Tanzanian Ministry of Health. This collaboration aims to validate the use of Artificial Intelligence in screening for diabetic retinopathy (DR) in low-resource settings….